<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04368416</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02928-49</org_study_id>
    <nct_id>NCT04368416</nct_id>
  </id_info>
  <brief_title>Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints</brief_title>
  <acronym>MEM-ASA</acronym>
  <official_title>Prevalence of Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of MEM-ASA is to investigate the prevalence of anxiety/depression, sleep
      disturbances and alcohol use disorder in elderly with cognitive complaints.

      In memory clinics of Normandy (France), all patients aged over 50 year-old are systematically
      questioned about anxiety, depression, sleep quality and alcohol use disorder. They also
      perform a neuropsychological assessment. Questionnaires are given to the patient and his/her
      caregiver to be filled in at home.

      Levels of anxiety/depression, sleep quality and alcohol consumption are related to
      neuropsychological performance, diagnosis and responses to the questionaires.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>At inclusion</time_frame>
    <description>Responses to questions during anamnesis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>At inclusion</time_frame>
    <description>Responses to questions during anamnesis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alcohol use disorder</measure>
    <time_frame>At inclusion</time_frame>
    <description>Responses to questions during anamnesis</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Anxiety State</condition>
  <condition>Sleep Disturbance</condition>
  <condition>Alcohol Abuse</condition>
  <condition>Aging</condition>
  <condition>Dementia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of memory clinics in Normandy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To have cognitive complaints

          -  To have french as native language

          -  Not to be opposed to be included

          -  To be affiliated to the social security

        Exclusion Criteria:

        -To be under tutorship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre BRANGER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU CAEN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre BRANGER, MD</last_name>
    <phone>33231065548</phone>
    <email>branger-p@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne Lise PITEL, PhD</last_name>
    <phone>33231470125</phone>
    <email>anne-lise.pitel@unicaen.fr</email>
  </overall_contact_backup>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>April 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>July 17, 2020</last_update_submitted>
  <last_update_submitted_qc>July 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

